Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form
Reexamination Certificate
2006-04-11
2006-04-11
Kishore, Gollamudi S. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
C514S011400
Reexamination Certificate
active
07025975
ABSTRACT:
A pharmaceutical composition containing macrolide, e.g. a rapamycin compound in an emulsion preconcentrate or microemulsion preconcentrate for oral administration. The carrier medium for the rapamycin compound includes a hydrophilic phase, a lipophilic phase and a surfactant. The composition is stable and provides high absorption efficiency.
REFERENCES:
patent: 3929992 (1975-12-01), Sehgal et al.
patent: 4388307 (1983-06-01), Cavanak
patent: 4678807 (1987-07-01), Cotter et al.
patent: 4678808 (1987-07-01), Ward et al.
patent: 4719239 (1988-01-01), Muller et al.
patent: 4831018 (1989-05-01), Kirsh et al.
patent: 4987139 (1991-01-01), Chen et al.
patent: 5104871 (1992-04-01), Bell et al.
patent: 5169851 (1992-12-01), Hughes et al.
patent: 5190950 (1993-03-01), Beattie et al.
patent: 5206018 (1993-04-01), Sehgal et al.
patent: 5215995 (1993-06-01), Honbo et al.
patent: 5318895 (1994-06-01), Kahn et al.
patent: 5342625 (1994-08-01), Hauer et al.
patent: 5510118 (1996-04-01), Bosch et al.
patent: 5527537 (1996-06-01), Dietl
patent: 5534270 (1996-07-01), De Castro
patent: 5536729 (1996-07-01), Waranis et al.
patent: 5559121 (1996-09-01), Harrison et al.
patent: 5561140 (1996-10-01), Kawai et al.
patent: 5622714 (1997-04-01), Dietl
patent: 5741512 (1998-04-01), Hauer et al.
patent: 5932243 (1999-08-01), Fricker
patent: 558 155 (1983-08-01), None
patent: 895 724 (1983-07-01), None
patent: 2133177 (1995-03-01), None
patent: 679 118 (1991-12-01), None
patent: 43 22 826 (1995-01-01), None
patent: 43 29 503 (1995-03-01), None
patent: 0 041 795 (1981-12-01), None
patent: 0 184 162 (1986-06-01), None
patent: 0 202 837 (1986-11-01), None
patent: 0 302 370 (1989-02-01), None
patent: 0 361 928 (1990-04-01), None
patent: 0 401 747 (1990-12-01), None
patent: 401747 (1990-12-01), None
patent: 0 423 714 (1991-04-01), None
patent: 0 427 680 (1991-05-01), None
patent: 0 428 169 (1991-05-01), None
patent: 0 444 659 (1991-09-01), None
patent: 0 483 842 (1992-05-01), None
patent: 0 499 299 (1992-08-01), None
patent: 0 507 556 (1992-10-01), None
patent: 0 509 795 (1992-10-01), None
patent: 0 512 754 (1992-11-01), None
patent: 0 532 862 (1993-03-01), None
patent: 0 533 433 (1993-03-01), None
patent: 0 552 031 (1993-07-01), None
patent: 0 577 215 (1994-01-01), None
patent: 0 589 843 (1994-03-01), None
patent: 0 648 494 (1995-04-01), None
patent: 0 649 659 (1995-04-01), None
patent: 0 650 730 (1995-05-01), None
patent: 0 868 911 (1998-10-01), None
patent: 907 430 (1962-10-01), None
patent: 1 322 306 (1973-07-01), None
patent: 2 015 339 (1979-09-01), None
patent: 2 221 157 (1990-01-01), None
patent: 2 222 770 (1990-03-01), None
patent: 2 247 620 (1992-03-01), None
patent: 2 248 184 (1992-04-01), None
patent: 2 249 027 (1992-04-01), None
patent: 2 257 359 (1993-01-01), None
patent: 2 271 121 (1994-04-01), None
patent: 6-183970 (1994-07-01), None
patent: 9-048737 (1997-02-01), None
patent: 95230 (1992-03-01), None
patent: 90/14094 (1990-11-01), None
patent: 91/19495 (1991-12-01), None
patent: 92/02229 (1992-02-01), None
patent: 92/14737 (1992-09-01), None
patent: 92/18105 (1992-10-01), None
patent: 92/21341 (1992-12-01), None
patent: 93/20833 (1993-10-01), None
patent: 96/25150 (1996-05-01), None
patent: 97/03654 (1997-02-01), None
patent: 96/13273 (1998-10-01), None
patent: 98/56358 (1998-12-01), None
Charman et al., Pharm. Res., vol. 9, No. 1, pp. 87-92 (1992).
Chemical Abstract of JP 85-133882 Jun. 19, 1985.
Schwarz et al. “Solid Lipid Nanoparticles (SLN) for Controlled Drug Delivery. I. Production, Characterization and Sterilization”, J Control Release, vol. 30, pp. 83-96 (1994).
Wrentlind, “Current Status of Intralipid and other Fat Emulsions”, Fat Emulsions in Parenteral Nutrition, Meng, HC and Wilmore, DW eds., JAMA, Chicago, pp. 109-122 (1976).
Fricker Gerd
Haeberlin Barbara
Meinzer Armin
Vonderscher Jacky
Kishore Gollamudi S.
Novartis AG
Savitsky Thomas R.
LandOfFree
Galenical formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Galenical formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Galenical formulations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3597092